Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans

Diabetologia

Volumn 49, Issue 10, 2006, Pages 2317-2328

  Richardson, D K ^a   Schneider, J ^b   Fourcaudot, M J ^a   Rodriguez, L M ^a   Arya, R ^a   Dyer, T D ^b   Almasy, L ^b   Blangero, J ^b   Stern, M P ^a   DeFronzo, R A ^a   Duggirala, R ^b   Jenkinson, C P ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Adiponectin; Adiponectin receptors; Association study; Genetics of type 2 diabetes mellitus; Insulin Resistance Syndrome; Single nucleotide polymorphisms

Indexed keywords

ADIPONECTIN RECEPTOR 1; TRIACYLGLYCEROL;

ADIPOQ GENE; ADIPOR1 GENE; ADIPOR2 GENE; ADULT; ARTICLE; BAYES THEOREM; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HISPANIC; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; PHENOTYPE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGED; BAYES THEOREM; BODY MASS INDEX; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MEXICAN AMERICANS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; TEXAS; VARIATION (GENETICS);

EID: 33748500005     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0384-3     Document Type: Article

References (50)

1. DeFronzo RA (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5:177-269
2. Bays H, Mandarino L, DeFronzo RA (2004) Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89:463-478
3. Reaven GM (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473-486
4. DeFronzo RA (1997) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 50:191-197
5. Groop LC, Bonadonna RC, Del Prato S, Ratheiser K, Zych K, DeFronzo RA (1989) Effect of insulin on oxidative and nonoxidative pathways of glucose and FFA metabolism in NIDDM. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205-213
6. Bergman RN, Finegood DT, Kahn SE (2002) The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32:35-45
7. Arner P (2001) Free fatty acids - do they play a role in insulin resistance? Diabetes Obes Metab 3:11-19
8. Groop L, Bonadonna R, Simonson DC, Petrides A, Hasan S, DeFronzo RA (1992) Effect of insulin on oxidative and nonoxidative pathways of glucose and free fatty acid metabolism in human obesity. Am J Physiol 263:79-84
9. McGarry JD (2001) Banting Lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7-18
10. Duggirala R, Blangero J, Almasy L et al (2001) A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. Am J Hum Genet 68:1149-1164
11. Duggirala R, Blangero J, Almasy L et al (2000) A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans. Am J Hum Genet 66:1237-1245
12. Elbein SC (2002) Perspective: the search for genes for type 2 diabetes in the post-genome era. Endocrinology 43:2012-2018
13. McCarthy M (2003) Growing evidence for diabetes susceptibility genes from genome scan data. Curr Diab Rep 3:159-167
14. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286-289
15. Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89
16. Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
17. Bajaj M, Suraamornkul S, Piper P et al (2004) Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89:200-206
18. Heilbronn LK, Smith SR, Ravussin E (2003) The insulinsensitizing role of the fat derived hormone adiponectin. Curr Pharm Des 9:1411-1418
19. Yamauchi T, Kamon J, Waki H et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
20. Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769
21. Civitarese AE, Jenkinson CP, Richardson DK et al (2004) Adiponectin receptors gene expression and insulin sensitivity in nondiabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 47:816-820
22. Gil-Campos M, Canete RR, Gil A (2004) Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 23:963-974
23. Yamauchi T, Kamon J, Minokoshi Y et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
24. Nakatani K, Noma K, Nishioka J et al (2005) Adiponectin gene variation associates with the increasing risk of type 2 diabetes in nondiabetic Japanese subjects. Int J Mol Med 15:173-177
25. Gu HF, Abulaiti A, Ostenson CG et al (2004) Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 53:31-S35
26. Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group (2005) The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 54:893-899
27. Vozarova de Courten B, Hanson RL, Funahashi T et al (2005) Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 54:284-289
28. Wang H, Zhang H, Jia Y et al (2004) Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance. Diabetes 53:2132-2136
29. Hara K, Horikoshi M, Kitazato H et al (2005) Absence of an association between the polymorphisms in the genes encoding adiponectin receptors and type 2 diabetes. Diabetologia 48:1307-1314
30. Damcott CM, Ott SH, Pollin TI et al (2005) Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes 54:2245-2250
31. Stefan N, Machicao F, Staiger H et al (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48:2282-2291
32. Stern MP, Gaskill SP, Hazuda HP, Gardner LI, Haffner SM (1983) Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study. Diabetologia 24:272-277
33. Stern MP, Mitchell BD, Blangero J et al (1996) Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes 45:563-568
34. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ (1984) Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol 120:834-851
35. Almasy L, Blangero J (1998) Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211
36. Abecasis GR, Cookson WOC, Cardon LR (2000) Pedigree tests of transmission disequilibrium. Eur J Hum Genet 8:545-551
37. Boerwinkle E, Chakraborty R, Sing CF (1986) The use of measured genotype information in the analysis of quantitative phenotypes in man. Ann Hum Genet 50:181-194
38. Almasy L, Blangero J (2004) Exploring positional candidate genes: linkage conditional on measured genotype. Behav Genet 34:173-177
39. Long AD, Lyman RF, Langley CH, Mackay TF (1999) Two sites in the Delta gene region contribute to naturally occurring variation in bristle number in Drosophila melanogaster. Genetics 149:999-1017
40. Phillips PC (1999) From complex traits to complex alleles. Trends Genet 15:6-8
41. Blangero J, Goring HH, Kent JW Jr et al (2005) Quantitative trait nucleotide analysis using Bayesian model selection. Hum Biol 77:541-559
42. Curran JE, Jowett JB, Elliott KS et al (2005) Genetic variation in selenoprotein S influences inflammatory response. Nat Genet 37:1234-1241
43. Almasy L, Blangero J (2004) Exploring positional candidate genes: linkage conditional on measured genotype. Behav Genet 34:173-177
44. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881
45. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953
46. Trujillo ME, Scherer PE (2005) Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167-175
47. Chan DC, Watts GF, Ng TW et al (2005) Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin Chem 51:578-585
48. Hamsten A, Silveira A, Boquist S et al (2005) The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. J Am Coll Cardiol 45:1013-1017
49. Staiger H, Kaltenbach S, Staiger K et al (2004) Expression of adiponectin receptor mRNA in human skeletal muscle cells is related to in vivo parameters of glucose and lipid metabolism. Diabetes 53:2195-2201
50. Populaire C, Mori Y, Dina C et al (2003) Does the -11377 promoter variant of APM1 gene contribute to the genetic risk for Type 2 diabetes mellitus in Japanese families? Diabetologia 46:443-445